Skip to search formSkip to main contentSkip to account menu

everolimus 0.25 MG Oral Tablet [Zortress]

Known as: Zortress 0.25 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

9 relations
Butylated HydroxytolueneCrospovidoneLactose MonohydrateMagnesium stearate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Intranasal Administration of Benzodiazepines for the Treatment of Acute Repetitive Seizures in Children
dministration of antiepileptics in children with acute repetitive seizures outside of the hospital setting is often difficult. At… 
2013
2013
Everolimus: A Guide to Its Use in Liver Transplantation
The mammalian target of rapamycin inhibitor everolimus (Zortress®, Certican®) was recently approved in the USA and a number of EU… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)